Week of November 09-15, 2026
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Of the 15 ticker analyses published this week, 11 carried a Hold signal, 2 a Buy (Sandisk and TSMC) and 2 a Sell (Applied Digital and Relay Therapeutics). The pattern was familiar: strong growth was easy to find, and a price that fully reflects it was not. Several of the names covered, including AbbVie, Eli Lilly and Apple, were at or near two-year highs when the model scored them, and the Opportunity pillar is where most of them lost ground. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
By The Numbers
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Across 190 stocks on the StreetBriefs watchlist, snapshot as of 2026-10-20. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
This Week’s Highlights
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sandisk: a Buy signal on a single-digit P/ESandisk was the week’s highest-scoring name, with a Buy signal, a P/E of 7.07 and trailing revenue growth of 377.9%. Quality scored 0.94, Growth 1.00 and Opportunity 0.83. Why It Matters
A low multiple on a very fast-growing business is rare, but the article flags that cash flow lags profit. Figures like these can reverse quickly in a cyclical industry, so the cash-conversion question is worth watching. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SPCX: 161% growth against a 57x EV/Revenue multipleSpace Exploration Technologies reported trailing revenue growth of 161.4% and scored 0.80 on Growth, but only 0.09 on Opportunity. Its P/E is 604.83, and the model’s signal is Hold. Why It Matters
This is the week’s clearest case of growth and valuation pulling in opposite directions. A multiple this high leaves little room for error if growth slows. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
UnitedHealth: strong on valuation, weak on growthUnitedHealth Group scored 0.73 on Opportunity, the highest of any Hold this week, with a P/E of 22.74. Trailing revenue growth was -0.4%, and the Growth score was 0.31. Why It Matters
It is the mirror image of SPCX: a better valuation score with a stalled top line. Whether a lower valuation is compensation or a warning depends on whether revenue growth returns. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Signal Changes This Week: NVDA (Hold → Buy)
Nvidia (NVDA) moved from Hold to Buy in the model’s latest reading. Quality was unchanged at 93/100 and Growth edged from 90/100 to 91/100. The main shift was valuation: the P/E fell from 26.90 to 23.60, EV/EBITDA from 25.67 to 22.23, and the Opportunity score rose from 26/100 to 31/100. FCF yield moved from 0.8% to 0.9%, while revenue growth (105.9%), gross margin (74.7%) and operating margin (66.2%) were unchanged. In other words, the change came from the price becoming less demanding relative to earnings, not from a change in the business metrics. It is a model output for further research, not a recommendation to transact. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
This Week’s Top 10
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quality / Growth / Opportunity scored 0-100. Ranked by the model’s overall conviction (RecScore). |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
With so many strong businesses scoring low on valuation, it may be worth watching whether Opportunity scores improve as prices and earnings move. As always, the signals are a starting point for your own research. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Browse all analyses on the site Track these companies on the same model in Qubits Finance → |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
StreetBriefs – get this digest in your inbox every Monday. Subscribe → StreetBriefs is a financial publisher, not an investment adviser. Buy/Hold/Sell reflects our quantitative scoring model – a data-driven signal for further research, not personalized investment advice. This newsletter is for informational purposes only; always do your own due diligence and consult a licensed financial advisor before making investment decisions. |
Nvidia moves from Hold to Buy as 11 of 15 analyses this week stayed at Hold
1
Subscribe
Login
0 Comments
Oldest
